Comparison of Gemcitabine Versus the Matrix Metalloproteinase Inhibitor BAY 12-9566 in Patients With Advanced or Metastatic Adenocarcinoma of the Pancreas: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group

Publication | Closed Access

DOI

396

Citations

References

2003

Year

Michael J. Moore, John Hamm, Janet Dancey, Peter D. Eisenberg, M. Dagenais, Anthony Fields, Kennecke Hagan, Bernard R. Greenberg, Brian Colwell, Benny Zee,

Journal of Clinical Oncology

Abstract

References